Summary

The Stroke Disease and Therapy Review provides an overview of the condition, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment for different types of strokes. Dosing and treatment cost information is provided for various treatment types and for medication. General information on thestroke market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format.  These reports are prepared by the senior market research team of Timely Data Resources.  Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities.  Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends.  The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment.  This information is supplemented by reviews of analyst reports, company reports, and medical websites.  Sources and references are provided. 

I. OVERVIEW
General description of the condition
Types of stroke
Symptoms

II. INCIDENCE, PREVALENCE AND MORTALITY
Incidence Table (Canada, US, Brazil, England, France, Germany, Italy, Scotland, Spain, UK, China, India, Japan, Worldwide)
Prevalence Table (Canada, US, Brazil, Mexico, England, France, Germany, Greece, Ireland, Italy, Poland, Romania, Scotland, Spain, Sweden, UK, China, India, Japan, Thailand, Australia, European Union, Worldwide)
Mortality Table (Canada, US, Brazil, Mexico, England and Wales, France, Germany, Greece, Italy, Poland, Russian Federation, Spain, UK, China, India, Japan, Republic of Korea, Democratic Republic of Congo, Australia, New Zealand, Worldwide)

III. TREATMENT
Ischemic strokes
Hemorrhagic strokes

IV. DOSING AND TREATMENT COSTS
Overall treatment costs
Costs for commonly prescribed non-generic drugs

V. MARKET SIZE
Market overview
Sales information for key pharmaceuticals

VI. FUTURE THERAPIES
VII. COMMENTS
VIII. REFERENCES/RESOURCES